Safety and efficay assessment of adenosine A2A receptor ligand [C-11]Preladenant in healthy volunteers.
Phase 1
- Conditions
- Healthy volunteer
- Registration Number
- JPRN-UMIN000019999
- Lead Sponsor
- Tokoyo Metropolitan Institute of Gerontology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
1.The subject who has dysfunction in the liver / kidney. 2.The subject who has abnormal findings in the central nervous system. 3.The subject having cardiac failure. 4.The subject with a history of a drug or food allergy. 5.The subject who juddged by the clinical investigator to be inappropriate as a participant in this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety: Adverse Drug Reaction (symptoms, blood pressure, respiratory rate, heart rate, general blood tests) Efficacy: Quality and analyzability of PET/CT image. Dosimetry Date of evaluation: on the day and one week after the PET scan
- Secondary Outcome Measures
Name Time Method